Scott M. Ocheltree

559 total citations
12 papers, 454 citations indexed

About

Scott M. Ocheltree is a scholar working on Oncology, Biochemistry and Neurology. According to data from OpenAlex, Scott M. Ocheltree has authored 12 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Biochemistry and 3 papers in Neurology. Recurrent topics in Scott M. Ocheltree's work include Drug Transport and Resistance Mechanisms (6 papers), Amino Acid Enzymes and Metabolism (4 papers) and Barrier Structure and Function Studies (3 papers). Scott M. Ocheltree is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Amino Acid Enzymes and Metabolism (4 papers) and Barrier Structure and Function Studies (3 papers). Scott M. Ocheltree collaborates with scholars based in United States, France and Singapore. Scott M. Ocheltree's co-authors include David E. Smith, Richard F. Keep, Yongjun Hu, Hong Shen, Richard D. Egleton, Brian T. Hawkins, Jianming Xiang, Thomas P. Davis, Marcus Hompesch and Scott J. Jacober and has published in prestigious journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics and Pharmaceutical Research.

In The Last Decade

Scott M. Ocheltree

12 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott M. Ocheltree United States	11	220	96	93	87	72	12	454
Salah Yousif France	8	399 1.8×	192 2.0×	183 2.0×	244 2.8×	62 0.9×	15	760
T. Kitazawa Japan	8	178 0.8×	101 1.1×	83 0.9×	32 0.4×	40 0.6×	15	363
Rong Zhao China	9	204 0.9×	120 1.3×	79 0.8×	51 0.6×	9 0.1×	16	400
Shizuo Yamada Japan	10	88 0.4×	55 0.6×	112 1.2×	20 0.2×	41 0.6×	11	308
Hitoshi Maegawa Japan	16	338 1.5×	127 1.3×	233 2.5×	19 0.2×	83 1.2×	26	664
Tomotaka Shingaki Japan	12	147 0.7×	85 0.9×	119 1.3×	17 0.2×	20 0.3×	16	429
Destiny B. Sykes United States	9	223 1.0×	122 1.3×	100 1.1×	61 0.7×	26 0.4×	12	342
Emi Hayashinaka Japan	13	112 0.5×	74 0.8×	123 1.3×	12 0.1×	34 0.5×	24	392
Kouichi Kawazu Japan	13	169 0.8×	113 1.2×	188 2.0×	46 0.5×	34 0.5×	29	616
Lucy Sanchez‐Covarrubias United States	7	220 1.0×	91 0.9×	160 1.7×	229 2.6×	35 0.5×	7	550

Countries citing papers authored by Scott M. Ocheltree

Since Specialization

Citations

This map shows the geographic impact of Scott M. Ocheltree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott M. Ocheltree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott M. Ocheltree more than expected).

Fields of papers citing papers by Scott M. Ocheltree

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott M. Ocheltree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott M. Ocheltree. The network helps show where Scott M. Ocheltree may publish in the future.

Co-authorship network of co-authors of Scott M. Ocheltree

This figure shows the co-authorship network connecting the top 25 collaborators of Scott M. Ocheltree. A scholar is included among the top collaborators of Scott M. Ocheltree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott M. Ocheltree. Scott M. Ocheltree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ocheltree, Scott M., et al.. (2010). Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes. European Journal of Endocrinology. 163(2). 217–223. 20 indexed citations

Hompesch, Marcus, Scott M. Ocheltree, Linda Morrow, et al.. (2009). Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes. Current Medical Research and Opinion. 25(11). 2679–2687. 31 indexed citations

Ye, Xiang S., Fan Li, Robert Van Horn, et al.. (2009). Abstract A62: A novel Eg5 inhibitor that causes mitotic arrest leading to rapid cancer cell death shows broad-spectrum antitumor activity in preclinical xenograft tumor models. Molecular Cancer Therapeutics. 8(12_Supplement). A62–A62. 2 indexed citations

Campos, Christopher, Scott M. Ocheltree, Sharon Hom, Richard D. Egleton, & Thomas P. Davis. (2008). Nociceptive inhibition prevents inflammatory pain induced changes in the blood–brain barrier. Brain Research. 1221. 6–13. 32 indexed citations

Shen, Hong, Scott M. Ocheltree, Yongjun Hu, Richard F. Keep, & David E. Smith. (2007). Impact of Genetic Knockout of PEPT2 on Cefadroxil Pharmacokinetics, Renal Tubular Reabsorption, and Brain Penetration in Mice. Drug Metabolism and Disposition. 35(7). 1209–1216. 66 indexed citations

Brooks, Tracy A., Scott M. Ocheltree, Melissa J. Seelbach, et al.. (2006). Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Research. 1120(1). 172–182. 46 indexed citations

Hawkins, Brian T., et al.. (2006). Decreased blood–brain barrier permeability to fluorescein in streptozotocin-treated rats. Neuroscience Letters. 411(1). 1–5. 67 indexed citations

Hu, Yongjun, Scott M. Ocheltree, Jianming Xiang, Richard F. Keep, & David E. Smith. (2005). Glycyl-l-Glutamine Disposition in Rat Choroid Plexus Epithelial Cells in Primary Culture: Role of PEPT2. Pharmaceutical Research. 22(8). 1281–1286. 17 indexed citations

Ocheltree, Scott M., Hong Shen, Yongjun Hu, Richard F. Keep, & David E. Smith. (2005). Role and Relevance of Peptide Transporter 2 (PEPT2) in the Kidney and Choroid Plexus: In Vivo Studies with Glycylsarcosine in Wild-Type and PEPT2 Knockout Mice. Journal of Pharmacology and Experimental Therapeutics. 315(1). 240–247. 70 indexed citations

10.

Ocheltree, Scott M., Hong Shen, Yongjun Hu, et al.. (2004). Mechanisms of Cefadroxil Uptake in the Choroid Plexus: Studies in Wild-Type and PEPT2 Knockout Mice. Journal of Pharmacology and Experimental Therapeutics. 308(2). 462–467. 40 indexed citations

11.

Ocheltree, Scott M., Hong Shen, Yongjun Hu, et al.. (2004). Role of PEPT2 in the Choroid Plexus Uptake of Glycylsarcosine and 5-Aminolevulinic Acid: Studies in Wild-Type and Null Mice. Pharmaceutical Research. 21(9). 1680–1685. 32 indexed citations

12.

Ocheltree, Scott M., Richard F. Keep, Hong Shen, et al.. (2003). Preliminary Investigation into the Expression of Proton-Coupled Oligopeptide Transporters in Neural Retina and Retinal Pigment Epithelium (RPE): Lack of Functional Activity in RPE Plasma Membranes. Pharmaceutical Research. 20(9). 1364–1372. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact